LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
Late to investing? Here are Dr James Fox’s favourite FTSE 100 stocks right now
Investing Articles
2 overlooked UK shares to consider for dividend income
Investing Articles
These undervalued FTSE 100 shares could rise more than 50% over the next year, according to brokers
Investing Articles
After crashing 50%+, is this a bargain-basement growth stock?
Investing Articles
A $236bn growth opportunity!? Is this FTSE 100 stock about to skyrocket?
Investing Articles
Could this ‘average’ FTSE 100 stock be one to consider in these difficult times?
Investing Articles
Is this FTSE 100 share a screaming buy to consider after recent falls?
Investing Articles
As the US stock market dives, here’s what Warren Buffett’s doing
Investing
This FTSE 100 stock looks good to me and I’d consider buying it now
Investing Articles
After earnings, is the Hikma Pharmaceuticals share price due a bounce?
Investing Articles
The UK stock market is brimming with hidden value. Here are some top picks to consider in July